ANTIFUNGAL THERAPY - POTENTIAL INTERACTIONS WITH OTHER CLASSES OF DRUGS

Authors
Citation
Dr. Bickers, ANTIFUNGAL THERAPY - POTENTIAL INTERACTIONS WITH OTHER CLASSES OF DRUGS, Journal of the American Academy of Dermatology, 31(3), 1994, pp. 190000087-190000090
Citations number
18
Categorie Soggetti
Dermatology & Venereal Diseases
ISSN journal
01909622
Volume
31
Issue
3
Year of publication
1994
Part
2
Supplement
S
Pages
190000087 - 190000090
Database
ISI
SICI code
0190-9622(1994)31:3<190000087:AT-PIW>2.0.ZU;2-D
Abstract
Combination drug therapy is widely used for the management of many com mon medical conditions. The concurrent use of more than one drug can s ignificantly alter the therapeutic and side-effect profile of each ind ividual agent. Such drug-drug interactions are generally classified ei ther as pharmacokinetic or pharmacodynamic. Oral agents used for the m anagement of superficial fungal infections can have both types of inte ractions. This article describes common drug-drug interactions observe d with amphotericin B, flucytosine, griseofulvin, ketoconazole, flucon azole, and itraconazole.